|
1
|
Brand PLP, Caudri D, Eber E, Gaillard EA,
Garcia-Marcos L, Hedlin G, Henderson J, Kuehni CE, Merkus PJ,
Pedersen S, et al: Classification and pharmacological treatment of
preschool wheezing: Changes since 2008. Eur Respir J. 43:1172–1177.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ducharme FM, Dell SD, Radhakrishnan D,
Grad RM, Watson WT, Yang CL and Zelman M: Diagnosis and management
of asthma in preschoolers: A Canadian Thoracic Society and Canadian
Paediatric Society position paper. Can Respir J. 22:135–143. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Beigelman A and Bacharier LB:
Infection-induced wheezing in young children. J Allergy Clin
Immunol. 133:603–604. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu YM, Jiang ZF, Shen K and Shen Y: Zhu
Fu-Tang Textbook of Paediatrics8th. People's Medical Publishing;
Beijing: 2012
|
|
5
|
El-Gamal YM and El-Sayed SS: Wheezing in
infancy. World Allergy Organ J. 4:85–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrante G and La Grutta S: The Burden of
Pediatric Asthma. Front Pediatr. 6:1862018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rodríguez-Martínez CE, Sossa-Briceño MP
and Castro-Rodriguez JA: Factors predicting persistence of early
wheezing through childhood and adolescence: A systematic review of
the literature. J Asthma Allergy. 10:83–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rossi GA and Colin AA: Infantile
respiratory syncytial virus and human rhinovirus infections:
Respective role in inception and persistence of wheezing. Eur
Respir J. 45:774–789. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu YF, Su MW, Chiang BL, Yang YH, Tsai CH
and Lee YL: A simple prediction tool for inhaled corticosteroid
response in asthmatic children. BMC Pulm Med. 17:1762017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye Q, He XO and D'Urzo A: A Review on the
Safety and Efficacy of Inhaled Corticosteroids in the Management of
Asthma. Pulm Ther. 3:1–18. 2017. View Article : Google Scholar
|
|
11
|
Turunen R, Koistinen A, Vuorinen T, Arku
B, Söderlund-Venermo M, Ruuskanen O and Jartti T: The first
wheezing episode: Respiratory virus etiology, atopic
characteristics, and illness severity. Pediatr Allergy Immunol.
25:796–803. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Piedimonte G, Renzetti G, Auais A, Di
Marco A, Tripodi S, Colistro F, Villani A, Di Ciommo V and Cutrera
R: Leukotriene synthesis during respiratory syncytial virus
bronchiolitis: Influence of age and atopy. Pediatr Pulmonol.
40:285–291. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Zhou J, Zhao X and Yi X:
Montelukast Treatment of Acute Asthma Exacerbations in Children
Aged 2 to 5 Years: A Randomized, Double-Blind, Placebo-Controlled
Trial. Pediatr Emerg Care. 34:160–164. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hosoki K, Kainuma K, Toda M, Harada E,
Chelakkot-Govindalayathila AL, Roeen Z, Nagao M,
D'Alessandro-Gabazza CN, Fujisawa T and Gabazza EC: Montelukast
suppresses epithelial to mesenchymal transition of bronchial
epithelial cells induced by eosinophils. Biochem Biophys Res
Commun. 449:351–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park JS, Jang AS, Park SW, Lee YM, Uh ST,
Kim YH, Cha JY, Park SM and Park CS: Protection of leukotriene
receptor antagonist against aspirin-induced bronchospasm in
asthmatics. Allergy Asthma Immunol Res. 2:48–54. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ernst P and Ernst G: Neuropsychiatric
adverse effects of montelukast in children. Eur Respir J.
50:502017. View Article : Google Scholar
|
|
17
|
Hossny E, Rosario N, Lee BW, Singh M,
El-Ghoneimy D, Soh JY and Le Souef P: The use of inhaled
corticosteroids in pediatric asthma: Update. World Allergy Organ J.
9:262016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chung KF, Caramori G and Adcock IM:
Inhaled corticosteroids as combination therapy with beta-adrenergic
agonists in airways disease: Present and future. Eur J Clin
Pharmacol. 65:853–871. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van Aalderen WMC and Sprikkelman AB:
Inhaled corticosteroids in childhood asthma: The story continues.
Eur J Pediatr. 170:709–718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kovesi T, Schuh S, Spier S, Bérubé D, Carr
S, Watson W and McIvor RA: Achieving control of asthma in
preschoolers. CMAJ. 182:E172–E183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Castro-Rodriguez JA and Rodrigo GJ:
Efficacy of inhaled corticosteroids in infants and preschoolers
with recurrent wheezing and asthma: A systematic review with
meta-analysis. Pediatrics. 123:e519–e525. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pawankar R, Holgate ST and Rosenwasser LJ:
Allergy Frontiers: Therapy and PreventionSpringer; Tokyo: 2010
|
|
23
|
Amirav I, Newhouse MT, Minocchieri S,
Castro-Rodriguez JA and Schüepp KG: Factors that affect the
efficacy of inhaled corticosteroids for infants and young children.
J Allergy Clin Immunol. 125:1206–1211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lan WP, Wang J, Dai CL and Pan JH:
Efficacy of fluticasone propionate aerosol versus budesonide
suspension in treatment of recurrent wheezing caused by
bronchiolitis. Zhongguo Dang Dai Er Ke Za Zhi. 18:316–319. 2016.(In
Chinese). PubMed/NCBI
|
|
25
|
Engelkes M, Janssens HM, de Jongste JC,
Sturkenboom MCJM and Verhamme KMC: Prescription patterns, adherence
and characteristics of non-adherence in children with asthma in
primary care. Pediatr Allergy Immunol. 27:201–208. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Makhinova T, Barner JC, Richards KM and
Rascati KL: Asthma Controller Medication Adherence, Risk of
Exacerbation, and Use of Rescue Agents Among Texas Medicaid
Patients with Persistent Asthma. J Manag Care Spec Pharm.
21:1124–1132. 2015.PubMed/NCBI
|
|
27
|
Wardenier NRA, Klok T, de Groot EP and
Brand PLP: Height growth in children with asthma treated with
guideline-recommended dosages of fluticasone and electronically
assessed adherence. Arch Dis Child. 101:637–639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blais L, Kettani FZ, Forget A, Beauchesne
MF, Lemière C and Ducharme FM: Assessing adherence to inhaled
corticosteroids in asthma patients using an integrated measure
based on primary and secondary adherence. Eur J Clin Pharmacol.
73:91–97. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vasbinder EC, Goossens LMA, Rutten-van
Mölken MPMH, de Winter BC, van Dijk L, Vulto AG, Blankman EI,
Dahhan N, Veenstra-van Schie MT, Versteegh FG, et al: e-Monitoring
of Asthma Therapy to Improve Compliance in children (e-MATIC): A
randomised controlled trial. Eur Respir J. 48:758–767. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leigh R, Vethanayagam D, Yoshida M, Watson
RM, Rerecich T, Inman MD and O'Byrne PM: Effects of montelukast and
budesonide on airway responses and airway inflammation in asthma.
Am J Respir Crit Care Med. 166:1212–1217. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stanford RH, Shah M and Chaudhari SL:
Clinical and economic outcomes associated with low-dose fluticasone
propionate versus montelukast in children with asthma aged 4 to 11
years. Open Respir Med J. 6:37–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
